Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001:(2):CD003040.
doi: 10.1002/14651858.CD003040.

Angiotensin receptor blockers for heart failure

Affiliations

Angiotensin receptor blockers for heart failure

Phillip Jong et al. Cochrane Database Syst Rev. 2001.

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To determine the efficacy of ARBs on the survival of patients with heart failure when compared to placebo or ACEIs.To determine the efficacy of ARBs on hospitalization rates in patients with heart failure when compared to placebo or ACEIs.

PubMed Disclaimer

References

    1. Ardaillou R. Angiotensin II receptors. J Am Soc Nephrol. 1999;10(Suppl 11):S30–S39. [MEDLINE: 87] - PubMed
    1. Brunner-La Rocca HP, Vaddadi G, Esler MD. Recent insight into therapy of congestive heart failure: focus on ACE inhibition and angiotensin-II antagonism. J Am Coll Cardiol. 1999;33(5):1163–1173. [MEDLINE: 81] - PubMed
    1. Clarke M, Oxman AD. Review Manager (RevMan). Version 4.0. The Cochrane Collaboration; Oxford, England: 1999. Cochrane Reviewers’ Handbook 4.0. [MEDLINE: 90200]
    1. Davie AP, Dargie HJ, McMurray JJ. Role of bradykinin in the vasodilator effects of losartan and enalapril in patients with heart failure. Circulation. 1999 Jul 20;100(3):268–273. [MEDLINE: 95] - PubMed
    1. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–188. [MEDLINE: 90116] - PubMed

LinkOut - more resources